https://www.selleckchem.com/products/hg6-64-1.html
Background Immunotherapy targeting PD-1/PD-L1 represents a breakthrough in the treatment of lung cancer. Pyruvate kinase M2 (PKM2) is not only a critical player in glycolysis, but also conducive to tumor progression and immune response. While both have been linked to lung adenocarcinoma (AC), the correlation and clinical significance of PKM2 and PD-L1 expression in human lung AC tissues remains not entirely explored. Methods Expression of PKM2 and PD-L1 proteins were detected by immunohistochemistry in 74 lung AC cases and the correspo
Like
Comment
Share
